CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Bristol Myers Squibb Ireland's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 31, 2025
Patent NumberGrant DateTitleTotal Oppositions
Nov 13, 2019Apixaban Formulations12
Oct 16, 2019Apixaban Formulations10
Oct 16, 2019Apixaban Formulations10
Dec 5, 2018Apixaban Formulations9
Jul 25, 2018Hiv Treatment Formulation Of Atazanavir And Cobicistat1